Pfizer buys Array Biopharma for $11.4 billion, sending shares of Array up 57%. Ron Gross analyzes the acquisition spree among big pharmaceutical companies. Target has a massive outage over the weekend, but we still have a few more questions about why. Plus, we dip into the Fool Mailbag and discuss the latest news from Papa John’s. Thanks to Sprout Social for supporting Motley Fool. To learn how your brand can create real connection, visit sproutsocial.com/fool today.
On this week’s episode of Industry Focus: Financials host Jason Moser sits down with Brendan Mathews, VP of Motley Fool Ventures to talk about working in venture capital, the types of companies they're looking at, the differences between public and private investing and some of the big trends the team is following!
Whether they are doing it because they need to or because they want to, people are more often likely to work later in life or opt for a semi-retirement. We’re joined by AARP’s Susan Weinstock to talk about why this trend isn’t going to change, and how you can plan for the realities of a later retirement.
Real people, Real brands, Real connection. Go to sproutsocial.com slash to learn more.
Download the FREE guide, “Seven Key Strategies to Grow your Profits” today at NetSuite.com/fool
Lululemon takes a breather. Casey’s General Store hits a new high. Restoration Hardware raises the roof. And Blue Apron delivers a reverse stock split. Analysts Andy Cross, Ron Gross, and Jason Moser discuss those stories and weigh in on Chewy’s IPO, Dave & Buster’s earnings, and bad bank names. Plus, Motley Fool co-founder David Gardner talks with 2U CEO Chip Paucek about the future of education.
Joseph Roux once said, "A fine quotation is a diamond on the finger of a man of wit, and a pebble in the hand of a fool." Whether held to the light to shine and inspire, or tossed into a pond to ripple outward, today's show is full of rock-solid advice on investing and life.
Get more great information on becoming a better investor -- free and straight to your inbox!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Statement and Terms & Conditions.